AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12466367
Drug: Combined Hormones
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined Hormones (GHT)
Trial: 3051673
Drug: Dexamethasone acetate
RxNorm normalized name: Dexamethasone Acetate
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone acetate (4 mg four times a day)
Trial: 12844393
Drug: Enterostatin (ENT)
RxNorm normalized name: Pentostatin
DrugBank: Pentostatin (DB00552)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enterostatin (ENT) 3 x 15 mg/d
Trial: 31949084
Drug: GIP infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GIP infusion (6 pmol/kg/min)
Trial: 18775846
Drug: Estrogen therapy
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen therapy (ET; 1 mg/day for 6 months)
Trial: 394624
Drug: Pentazocine 15
RxNorm normalized name: pentazocine 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentazocine 15 mg
Trial: 1339011
Drug: Cisplatinum 20
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatinum 20 mg/m2/day + Etoposide 60 mg/m2/day (arm A)
Trial: 21314751
Drug: Patients who
RxNorm normalized name: MAYZENT 0.25mg Tablet Starter Pack (For Patients Who Will Receive The 2mg Maintenance Dosage)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients who consistently named multiple drug users in their social networks
Trial: 12923684
Drug: Ibuprofen phonophoresis
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen phonophoresis (PH)
Trial: 28225186
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg of oltipraz twice daily for 24 weeks
Trial: 28225186
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg of oltipraz twice daily for 24 weeks
Trial: 24707145
Drug: 7-day regimen
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 7-day regimen of amoxicillin 1 g, clarithromycin 500 mg, and rabeprazole 20 mg twice daily
Trial: 8723850
Drug: Intravenous midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous midazolam (7.5 mg)
Trial: 26753640
Drug: Delayed extended-release
RxNorm normalized name: Extended Release Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed extended-release formulation containing alpha-benzopyrone (Coumarin), benzo-gamma-pyrone (Troxuretina), and oligomeric proanthocyanidins from Vitis vinifera (OPC) in addition to compression therapy
Trial: 20061421
Drug: GH +
RxNorm normalized name: Delsym Cough + Cold Daytime
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH + Ox 0.06 mg/kg . d
Trial: 8643970
Drug: 1-hour infusion
RxNorm normalized name: coagulation factor IX recombinant immunoglobulin G1 fusion protein 1 UNT [Alprolix]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-hour infusion of paclitaxel at 135 mg/m2
Trial: 2239934
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human erythropoietin (r‐HuEPO) therapy
Trial: 27867128
Drug: Meropenem 1
RxNorm normalized name: meropenem 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meropenem 1 g every 6 hours
Trial: 29037063
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 (5000 or 50,000 IUs weekly) for depression treatment
Trial: 19378437
Drug: Intramuscular testosterone
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular testosterone treatment
Trial: 8868311
Drug: Atrial natriuretic
RxNorm normalized name: Atrial natriuretic factor
DrugBank: Atrial natriuretic peptide (DB15591)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atrial natriuretic peptide (ANP) infusion (0.3 microgram/kg/min)
Trial: 22496156
Drug: Randomized dose
RxNorm normalized name: jojoba oil, randomized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Randomized dose strategy, platelet source, ABO compatibility, and duration of storage
Trial: 20472113
Drug: Combined oral
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined oral contraceptive (OC)
Trial: 22094904
Drug: BMMSC treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BMMSC treatment
Trial: 22094904
Drug: Core decompression
RxNorm normalized name: diclofenac
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Core decompression (CD) treatment
Trial: 22237175
Drug: Cytomegalovirus therapeutic
RxNorm normalized name: cytomegalovirus immunoglobulin
DrugBank: Human cytomegalovirus immune globulin (DB13886)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytomegalovirus therapeutic DNA vaccine (TransVax)
Trial: 30573004
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of prednisolone
Trial: 23651816
Drug: Intracoronary infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary infusion of bone marrow mesenchymal stem cells (BMSCs); n=21
Trial: 29226570
Drug: Sirolimus-based therapy
RxNorm normalized name: Sirolimus
DrugBank: Sirolimus (DB00877)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Sirolimus-based therapy
Trial: 9031103
Drug: Aggressive chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aggressive chemotherapy
Trial: 18620577
Drug: AM-L
RxNorm normalized name: L-377202
DrugBank: L-377202 (DB19022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AM-L
Trial: 8911112
Drug: Dolasetron mesilate
RxNorm normalized name: Dolasetron mesilate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dolasetron mesilate 200 mg
Trial: 1911501
Drug: 5-mg MS
RxNorm normalized name: morphine
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5-mg MS bolus and subsequent saline infusion (n = 13)
Trial: 2691478
Drug: Cefotaxime 100
RxNorm normalized name: cefotaxime 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime 100 mg/kg/d in four divided iv doses for 14 days
Trial: 7020917
Drug: L-phenylalanine mustard
RxNorm normalized name: L-Phenylalanine mustard
DrugBank: Melphalan (DB01042)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-phenylalanine mustard (L-PAM)
Trial: 23327021
Drug: Intravenous dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous dexamethasone (0.2 mg/kg)
Trial: 29998336
Drug: Immediate monitoring
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Immediate monitoring with a home-based wearable ECG patch
Trial: 29998336
Drug: Delayed monitoring
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Delayed monitoring with a home-based wearable ECG patch
Trial: 10326116
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg twice daily of nitazoxanide
Trial: 10326116
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg twice daily of nitazoxanide
Trial: 27684308
Drug: Linagliptin/metformin
RxNorm normalized name: LINAGLIPTIN/METFORMIN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linagliptin/metformin
Trial: 29901374
Drug: Vaginal conjugated
RxNorm normalized name: estrogens, conjugated (USP) Vaginal Cream [Premarin]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal conjugated equine estrogen (CEE) cream 0.5 g once a week
Trial: 20041428
Drug: Topical (0.5%)
RxNorm normalized name: Topicale
DrugBank: Benzocaine (DB01086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical (0.5%) Pycnogenol and oral Pycnogenol
Trial: 3349550
Drug: 150 ml
RxNorm normalized name: REBYOTA 150 ML Enema
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 ml coffee with oral ranitidine 150 mg (Group 4)
Trial: 8163257
Drug: Topical felbinac
RxNorm normalized name: felbinac Topical Foam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical felbinac
Trial: 1422972
Drug: Oral phosphate
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral phosphate 1500 mg/day
Trial: 9830318
Drug: LARR1 group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LARR1 group (induction with 4 days of etoposide and 4 days of high-dose ara-C)
Trial: 31030568
Drug: Atorvastatin 40
RxNorm normalized name: atorvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 40 mg/day (control group)
Trial: 28406125
Drug: Rosuvastatin 10
RxNorm normalized name: rosuvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin 10 mg OD for 24 weeks
Trial: 8140383
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (200 micrograms) aqueous nasal spray (FPANS) twice daily
Trial: 8140383
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate (200 micrograms) aqueous nasal spray (BDPANS) twice daily
Trial: 1662877
Drug: Temafloxacin 300
RxNorm normalized name: temafloxacin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temafloxacin 300 mg or 600 mg b.i.d.
Trial: 24866253
Drug: Brief Narrative
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Brief Narrative Exposure Therapy (brief NET), 3 sessions, conducted individually, in Arabic
Trial: 11807679
Drug: Voriconazole 6
RxNorm normalized name: Voriconazole
DrugBank: Voriconazole (DB00582)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Voriconazole 6 mg/kg b.i.d. for 2 doses, then 3 mg/kg b.i.d. for 6-27 days, followed by 200 mg b.i.d. orally for up to 24 weeks
Trial: 22283900
Drug: Antiretroviral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiretroviral treatment (ART) initiation
Trial: 10597783
Drug: APV 1200
RxNorm normalized name: FOS-APV
DrugBank: Fosamprenavir (DB01319)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: APV 1200 mg with 3TC/ZDV
Trial: 31177055
Drug: Human donor
RxNorm normalized name: Donor Human Stool
DrugBank: Fecal microbiota (DB17743)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human donor milk with >60 kcal/100 mL
Trial: 7639806
Drug: CD4 monoclonal
RxNorm normalized name: factor VIII
DrugBank: Beroctocog alfa (DB14473)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CD4 monoclonal antibody (MAb) cM‐T412
Trial: 8277144
Drug: Fluoxetine 20
RxNorm normalized name: fluoxetine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine 20 mg/day
Trial: 9579293
Drug: levodopa +
RxNorm normalized name: Levodopa
DrugBank: Levodopa (DB01235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: levodopa + apomorphine (1 mg/h)
Trial: 23262475
Drug: Intravenous bolus
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous bolus of 1.5 g of magnesium sulphate followed by an infusion of 12 g in 24 h
Trial: 7369096
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no anticoagulants)
Trial: 30668840
Drug: L-glutamic acid
RxNorm normalized name: L-Glutamic Acid
DrugBank: Glutamic acid (DB00142)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-glutamic acid inclusion levels: 3.28%
Trial: 30668840
Drug: L-glutamic acid
RxNorm normalized name: L-Glutamic Acid
DrugBank: Glutamic acid (DB00142)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-glutamic acid inclusion levels: 3.48%
Trial: 8031162
Drug: 5-FU tablets
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-FU tablets administered at a dose of 200 mg/day for 12 months
Trial: 1531044
Drug: Ondansetron 8
RxNorm normalized name: ondansetron 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 8 mg oral dose
Trial: 30304457
Drug: Oral dydrogesterone
RxNorm normalized name: Dydrogesterone
DrugBank: Dydrogesterone (DB00378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral dydrogesterone 30 mg daily
Trial: 20022990
Drug: Zoledronic acid
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronic acid (ZA) 4 mg iv every 3 months for 12 months
Trial: 2050831
Drug: Amiloride 10
RxNorm normalized name: amiloride 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiloride 10 mg daily
Trial: 12949315
Drug: Budesonide inhalation
RxNorm normalized name: Budesonide Inhalation Powder
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide inhalation suspension and cromolyn sodium
Trial: 6365017
Drug: Methadyl acetate
RxNorm normalized name: Methadyl acetate
DrugBank: Methadyl acetate (DB01433)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadyl acetate six days a week with diminishing doses on three days
Trial: 30497530
Drug: neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: neoadjuvant chemotherapy without bevacizumab
Trial: 21052775
Drug: Radiotherapy followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Radiotherapy followed by adjuvant temozolomide (150‐200 mg/m(2) for 5 days every 28 days)
Trial: 21962214
Drug: Intravenous immune
RxNorm normalized name: Intravenous immune globulin (human)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immune globulin (500 mg/kg)
Trial: 27860389
Drug: Canrenone 100
RxNorm normalized name: canrenone
DrugBank: Canrenone (DB12221)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Canrenone 100 mg
Trial: 17505429
Drug: Endovascular treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovascular treatment (ET) using Hemobahn/Viabahn endograft
Trial: 7378115
Drug: Preparation A
RxNorm normalized name: POVIDONE-IODINE 75 mg in 1 mL TOPICAL SOLUTION [Antiseptic Patient Preoperative Skin Preparation and Surgical Hand Scrub]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preparation A (hydrous solution, 1 mg F−/100 ml)
Trial: 10908898
Drug: Levetiracetam 3000
RxNorm normalized name: Levetiracetam
DrugBank: Levetiracetam (DB01202)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levetiracetam 3000 mg/day
Trial: 15093870
Drug: Ranolazine 1000
RxNorm normalized name: ranolazine 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranolazine 1000 mg twice daily
Trial: 25757171
Drug: Clopidogrel (Listab)
DrugBank: Clopidogrel (DB00758)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Clopidogrel (Listab) 75 mg/day
Trial: 19691426
Drug: Sitagliptin 100
RxNorm normalized name: SITagliptin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitagliptin 100 mg once daily
Trial: 97033
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg DSCG inhaled four times daily for 3 days
Trial: 4758424
Drug: Recently produced
RxNorm normalized name: RECOMBINANT DNA DERIVED B-DOMAIN DELETED PORCINE BLOODCOAGULATION FACTOR VIII ANALOGUE, PRODUCED IN BHK21 CELLS: DES-(753-1418)-BLOOD-COAGULATION FACTOR VIII (PROCOAGULANT COMPONENT) SUS SCROFA, GLYCOSYLATED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recently produced Lanoxin tablets (1.5 mg dose)
Trial: 2318517
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose hydrochlorothiazide (50-100 mg)
Trial: 29122360
Drug: More rigorous
RxNorm normalized name: polyurethane-35 (not more than MPA.S at 40 %)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: More rigorous dose calculation algorithm
Trial: 17235610
Drug: Citalopram 20
RxNorm normalized name: citalopram 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram 20 mg/day
Trial: 15842136
Drug: Mosapride Citrate
RxNorm normalized name: mosapride citrate
DrugBank: Mosapride (DB11675)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mosapride Citrate tablet
Trial: 8351043
Drug: Chewable antiplaque
RxNorm normalized name: cetylpyridinium
DrugBank: Cetylpyridinium (DB11073)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chewable antiplaque preparation containing chlorhexidine, fluoride, and xylitol
Trial: 3528964
Drug: Etoposide therapy
RxNorm normalized name: Etoposide
DrugBank: Etoposide (DB00773)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Etoposide therapy
Trial: 3528964
Drug: Multidrug therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multidrug therapy (VBAMDex)
Trial: 19935070
Drug: Gabapentin 600
RxNorm normalized name: gabapentin 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin 600 mg
Trial: 2610509
Drug: Cefixime 2
RxNorm normalized name: cefixime 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefixime 2 h before antacid
Trial: 2610509
Drug: Cefixime 2
RxNorm normalized name: cefixime 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefixime 2 h after antacid
Trial: 8110564
Drug: Ephedrine infusion
RxNorm normalized name: Ephedrine
DrugBank: Ephedrine (DB01364)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ephedrine infusion titrated between 0 and 120 mg h‐1
Trial: 29853660
Drug: AMG 706
RxNorm normalized name: AMG 108
DrugBank: AMG 108 (DB05545)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMG 706 (motesanib) 125 mg per day orally combined with octreotide long acting-repeatable (LAR)
Trial: 27193748
Drug: Zoledronic acid
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronic acid (ZOL) infusion (5 mg)
Trial: 23958252
Drug: Anacetrapib (ANA)
RxNorm normalized name: Ana-Lex
DrugBank: Anacetrapib (DB06630)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anacetrapib (ANA) co-administered with atorvastatin (ATV) 10 mg
Trial: 3214495
Drug: Lomefloxacin 400
RxNorm normalized name: lomefloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lomefloxacin 400 mg
Trial: 20514832
Drug: Chewing gum
RxNorm normalized name: Chewing Gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chewing gum (sugarless) for 30 minutes thrice daily until resumption of intestinal transit
Trial: 6324616
Drug: Captopril 3
RxNorm normalized name: Captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Captopril 3 mg/kg po
Trial: 11135227
Drug: Intratumoral injection
RxNorm normalized name: bimatoprost
DrugBank: Bimatoprost (DB00905)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intratumoral injection of 30 million autologous dendritic cells (DCs) per tumor after treatment with granulocyte‐macrophage‐colony stimulating factor and interleukin‐4.
Trial: 18751497
Drug: Amlodipine besylate
RxNorm normalized name: Amlodipine Besylate
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine besylate test formulation (10 mg)
Trial: 7738215
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of ranitidine (150 mg/24 hr)
Trial: 7738215
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of famotidine (40 mg/24 hr)
Trial: 30971750
Drug: Apple juice
RxNorm normalized name: apple juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apple juice treated with invertase, glucose oxidase/catalase (glucose 0.05 g; gluconate 18.2 g)
Trial: 1706014
Drug: Enalapril 20
RxNorm normalized name: enalapril 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 20 mg
Trial: 24634462
Drug: Nicotine Replacement
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine Replacement Therapy (NRT) - 15 mg/16 hr nicotine patches
Trial: 10987706
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with histories of injection drug abuse
Trial: 12888588
Drug: Meglumine antimoniate
RxNorm normalized name: meglumine antimoniate
DrugBank: Meglumine antimoniate (DB13732)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meglumine antimoniate 20 mg Sbv/kg/day for 28 days
Trial: 20423278
Drug: Yuzpe regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yuzpe regimen (high dose combined oral contraceptive pills)
Trial: 24457472
Drug: Arterial infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Arterial infusion of p53 gene (Gendicine)
Trial: 16796078
Drug: Fenofibrate 130
RxNorm normalized name: fenofibrate 130 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenofibrate 130 mg/day
Trial: 15203786
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of nicotine skin patches and mecamylamine